scPharmaceuticals Inc (SCPH)

Finanzdaten der scPharmaceuticals Inc-Aktie (SCPH)

Gewinn- und Verlustrechnung

Vierteljährlich

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	60.59% 6.096	3.796	1.638	2.063	-
Cost Of Revenue	64.32% 1.773	1.079	0.354	0.605	-
Gross Profit	59.11% 4.323	2.717	1.284	1.458	-
Operating Expenses	11.53% 19.58	17.56	15.03	13.01	9.502
Interest Income/Expense	1.55% 2.092	2.06	2.01	1.961	1.959
Benefits Costs and Expenses	2.46% 19.91	19.43	15.79	13.27	-
Costs And Expenses	2.46% 19.91	19.43	15.79	13.27	-
Operating Income/Loss	2.82% -15.26	-14.84	-13.75	-11.55	-9.502
Income/Loss From Continuing Operations Before Tax	11.65% -13.81	-15.63	-14.15	-11.21	-9.248
Income/Loss From Continuing Operations After Tax	11.65% -13.81	-15.63	-14.15	-11.21	-9.248
Net Income/Loss	11.65% -13.81	-15.63	-14.15	-11.21	-9.248
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	99.76% 0.0921	38.76	38.69	37.80	0.9757
Diluted Average Shares	99.76% 0.0921	38.76	38.69	37.80	0.9757
Basic Earnings Per Share	14.63% -0.35	-0.41	-0.36	-0.30	-0.29
Diluted Earnings Per Share	14.63% -0.35	-0.41	-0.36	-0.30	-0.29
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-